Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scopolamine Patch vs Acupressure for C-Section Nausea
NCT02960113Phase 4Completed
- Sponsor
- Rutgers University
- Start
- May 2016
- Primary completion
- Sep 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of scopolamine in nausea ((none)) and Vomiting (3 arms), sponsored by Rutgers University. Primary endpoints: Number of Patients With Nausea and Number of Patients With Vomiting. Started May 2016; status: completed.
02
Drugs
scopolamine
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT02960113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02960113.